| ID | 69496 |
| FullText URL | |
| Author |
Nakanoh, Hiroyuki
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Tsuji, Kenji
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
ORCID
Kaken ID
researchmap
Fukushima, Kazuhiko
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Uchida, Naruhiko
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Haraguchi, Soichiro
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Kitamura, Shinji
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Kaken ID
publons
Wada, Jun
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
ORCID
Kaken ID
publons
researchmap
|
| Abstract | Kidney organoids, derived from stem cells, including pluripotent stem cells and adult progenitor cells, have been reported as three-dimensional in vitro models that reflect key aspects of kidney development, structure, and function. Advances in differentiation protocols and tissue engineering have enabled the generation of organoids that exhibit nephron-like structures, including glomerular and tubular structures. Kidney organoids have been widely applied in several directions, including disease modeling and therapeutic screening, drug nephrotoxicity evaluation, and regenerative medicine. In particular, kidney organoids offer a promising platform for studying genetic kidney diseases, such as polycystic kidney disease and congenital anomalies of the kidney and urinary tract (CAKUT), by allowing patient-specific modeling for the analysis of pathophysiology and therapeutic screening. Despite several current limitations, such as incomplete maturation, lack of full nephron segmentation, and variability between protocols and cell conditions, further technological innovations such as microfluidics and bioengineering may refine kidney organoid systems. This review highlights recent advances in kidney organoid research, outlines major applications, and discusses future directions to enhance their physiological relevance, functional maturity, and translational integration into preclinical and clinical nephrology.
|
| Keywords | kidney organoid
stem cell
disease modeling
drug toxicity
drug screening
regenerative medicine
|
| Published Date | 2025-10-29
|
| Publication Title |
Life
|
| Volume | volume15
|
| Issue | issue11
|
| Publisher | MDPI AG
|
| Start Page | 1680
|
| ISSN | 2075-1729
|
| Content Type |
Journal Article
|
| language |
English
|
| OAI-PMH Set |
岡山大学
|
| Copyright Holders | © 2025 by the authors.
|
| File Version | publisher
|
| DOI | |
| Related Url | isVersionOf https://doi.org/10.3390/life15111680
|
| License | https://creativecommons.org/licenses/by/4.0/
|
| Citation | Nakanoh, H.; Tsuji, K.; Fukushima, K.; Uchida, N.; Haraguchi, S.; Kitamura, S.; Wada, J. Kidney Organoids: Current Advances and Applications. Life 2025, 15, 1680. https://doi.org/10.3390/life15111680
|
| 助成情報 |
( ウエスコ学術振興財団 / Wesco Scientific Promotion Foundation )
24K11411:
腎臓線維化におけるSemaphorin3A経路の病態機序の解明と治療への応用
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
|